Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$9.67M$9.67Mderived−7.0% vs Q4 2024 Net Income-$804.12K-$804.12KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$395,676N/M Operating Cash Flowderived$643,970N/M Free Cash Flowderived$587,347N/M Margins · derivedOperating margin-4.1%−3.2 pt vs Q4 2024
Net margin-8.3%−2.8 pt vs Q4 2024
ended Dec 31, 2025 · filed Apr 15, 2026 · 105 d after period end